Systemic exertion intolerance disease associated to neuroendocrine dysfunction and cortical atrophy: a case report

Fam Pract. 2023 Feb 9;40(1):195-199. doi: 10.1093/fampra/cmac060.

Abstract

Background: Scarce evidence about the organic and functional abnormalities of systemic exertion intolerance disease (SEID) is found in literature and the pathophysiology is still unclear.

Methods: Following the CARE Guidelines, this case report describes a patient with a 5-year history of nonspecific symptoms, lately recognized as SEID.

Results: Low serum thyroid- and adrenocorticotropic stimulating hormone levels, and 24-h urinary cortisol excretion almost twice the upper limit were detected. Computed tomography scan found significant cortical atrophy. Low-dose modafinil improved the clinical outcome, added to nonpharmacologic approach.

Conclusion: To ascertain an accurate SEID diagnosis and treatment are a challenge in daily clinical practice, that must be engaged based in clear methods and good practice recommendations. Thus, family practitioners should be aware of this diagnosis.

Keywords: case report; chronic fatigue syndrome; cognitive behavioural therapy; cortical atrophy; modafinil; myalgic encephalomyelitis; neuroendocrine dysfunction; systemic exertion intolerance disease.

Publication types

  • Case Reports

MeSH terms

  • Atrophy / complications
  • Fatigue Syndrome, Chronic* / diagnosis
  • Fatigue Syndrome, Chronic* / therapy
  • Humans